Liquid antisolvent precipitation process for solubility modulation of bicalutamide

Acta Pharmaceutica

Volumn 61, Issue 4, 2011, Pages 435-445

  Meer, Tarique Ali ^a   Sawant, Kiran P ^a   Amin, Purnima D ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

bicalutamide; dissolution rate; liquid antisolvent precipitation; solubility enhancement

Indexed keywords

BICALUTAMIDE; POLOXAMER;

ARTICLE; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; LIQUID ANTISOLVENT PRECIPITATION; PARTICLE SIZE; PRECIPITATION; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; THERMAL ANALYSIS; X RAY DIFFRACTION;

EID: 84855223012     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-011-0036-0     Document Type: Article

References (16)

1. D. R. Vega, G. Polla, A. Martinez, E. Mendioroz and M. Reionoso, Conformational polymorphism in bicalutamide, Int. J. Pharm. 328 (2007) 112-118; DOI: 10.1016/j.ijpharm.2006.08.001 (Pubitemid 44883401)
2. D. Wu, J. Yang, V. A. Nair, D. D. Miller and J. T. Dalton, Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: Implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic chrecteristics of a propanamide in preclinical study, Drug Metab. Dispos. 34 (2006) 483-494; DOI: 10.1124/dmd.105.006643 (Pubitemid 43290908)
3. Y. Le, H. Ji, J. F. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents, Int. J. Pharm. 370 (2009) 175-180; DOI: 10.1016/j.ijpharm.2008.11.025
4. A. Abdalla and K. Mäder, Preparation and characterization of a self-emulsifying pellet formulation, Eur. J. Pharm. Biopharm. 66 (2007) 220-226; DOI: 10.1016/j.ejpb.2006.11.015 (Pubitemid 46654779)
5. I. Kanfer, Report on the international workshop on the biopharmaceutics classification system (BCS): Scientific and regulatory aspects in practice, J. Pharm. Pharm. Sci. 5 (2000) 1-4
6. P. Kocbek, S. Baumgartner and J. Kristl, Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs, Int. J. Pharm. 312 (2006) 179-186; DOI: 10.1016/j.ijpharm.2006.01.008
7. Y. Dong, W. N. Kiong, S. Shen, S. Kim and R. B. H. Tan, Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation, Int. J. Pharm. 375 (2009) 84-88; DOI: 10.1016/j.ijpharm.2009.03.013
8. A. Balakrishnan, B. D. Rege, G. L. Amidon and J. E. Polli, Surfactant-mediated dissolution: Contributions of solubility enhancement and relatively low micelle diffusivity, J. Pharm. Sci. 93 (2004) 2064-2075; DOI: 10.1002/jps.20118 (Pubitemid 39045487)
9. G. S. Jadhav and P. R. Vavia, Physicochemical in silico and in-vivo evaluation of danazole-bcyclodextrin complex, Int. J. Pharm. 352 (2008) 5-16 DOI: 10.1016/j.ijpharm.2007.10.005 (Pubitemid 351284585)
10. I. Ilić, R. Dreu, M. Burjak, M. Homar Microparticle size control and glimepiride microencapsulation using spray congealing technology, Int. J. Pharm. 381 (2009) 176-183; DOI: 10.1016/j.ijpharm.2009.05.011
11. M. D. Moore and P. L. D. Wildfong, Aqueous solubility enhancement through engineering of binary solid composites: Pharmaceutical applications, J. Pharm. Innov. 4 (2009) 36-49; DOI: 10.1007/s12247-009-9053-7
12. P. Zhang, H. Ye, T. Min and C. Zhang, Water soluble poly(ethylene glycol) prodrug of silybin: Design, synthesis, and characterization, J. Appl. Polym. Sci. 107 (2008) 3230-3235; DOI: 10.1002/app.27450 (Pubitemid 351238758)
13. Y. Le, H. Ji, J. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents, Int. J. Pharm. 370 (2009) 175-180 DOI: 10.1016/j.ijpharm.2008.11.025
14. R. P. Bagwe and K. C. Khilar, Effects of the intermicellar exchange rate and cations on the size of silver chloride nanoparticles formed in reverse micelles of AOT, Langmuir 13 (1997) 6432-6438; DOI: 10.1021/la980248q (Pubitemid 127592056)
15. J. Y. Zhang, Z. G. Shen, J. Zhong, T. T. Hu, J. F. Chen, Z. Q. Ma and J. Yun, Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants, Int. J. Pharm. 323 (2006) 153-160; DOI: 10.1016/i.ijpharm.2006.05.048 (Pubitemid 44397363)
16. U. S. Food and Drug Administration, Dissolution Methods, Bicalutamide, FDA, Silver Sping (MD), Dec 15 2005; http://www.accessdata.fda.(MD)gov/scripts/ cder/dissolution/dsp- Search-Results-Dissolutions.cfm?PrintAll=1.